http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-89543-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc7bf0829e5b5379b6b367c6d5686ebe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_285e1dc5bf9e0a4dda1ca3fcb268620f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205
filingDate 2013-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41909163e523e557bc3c59e6ecb9e994
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d31b2118a6e5352c11f010b690b92852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5319f7728823bbfbdb0d02c81e35b1b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b255be3808ff2c71a2c109e6244e4b53
publicationDate 2014-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-89543-U
titleOfInvention Vaginal suppositories for the treatment of polycystic ovary syndrome
abstract Vaginal suppositories for the treatment of polycystic ovary syndrome contain a fatty base, the active substance metronidazole. Additionally, the active substances are administered clotrimazole, ibuprofen, progesterone and auxiliary substances DMSO, tween-80.
priorityDate 2013-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226

Total number of triples: 24.